HK1010193A1 - A process for the optical purification of enantiomerically enriched benzimidazole derivatives - Google Patents

A process for the optical purification of enantiomerically enriched benzimidazole derivatives

Info

Publication number
HK1010193A1
HK1010193A1 HK98110996.6A HK98110996A HK1010193A1 HK 1010193 A1 HK1010193 A1 HK 1010193A1 HK 98110996 A HK98110996 A HK 98110996A HK 1010193 A1 HK1010193 A1 HK 1010193A1
Authority
HK
Hong Kong
Prior art keywords
enantiomerically enriched
benzimidazole derivatives
optical purification
enriched benzimidazole
purification
Prior art date
Application number
HK98110996.6A
Other languages
English (en)
Inventor
Unge Sverker Von
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20397468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1010193(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1010193A1 publication Critical patent/HK1010193A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98110996.6A 1995-07-03 1998-09-26 A process for the optical purification of enantiomerically enriched benzimidazole derivatives HK1010193A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9500817 1995-07-03
PCT/SE1996/000841 WO1997002261A1 (fr) 1995-07-03 1996-06-26 Procede de purification optique pour derives de benzimidazole enrichis par enantiomorphe

Publications (1)

Publication Number Publication Date
HK1010193A1 true HK1010193A1 (en) 1999-06-17

Family

ID=20397468

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110996.6A HK1010193A1 (en) 1995-07-03 1998-09-26 A process for the optical purification of enantiomerically enriched benzimidazole derivatives

Country Status (37)

Country Link
US (1) US5929244A (fr)
EP (2) EP0836601B1 (fr)
JP (1) JP4195507B2 (fr)
KR (1) KR100451078B1 (fr)
CN (1) CN1098261C (fr)
AT (1) ATE418549T1 (fr)
AU (1) AU698638B2 (fr)
BR (1) BR9609450A (fr)
CA (1) CA2226184C (fr)
CZ (1) CZ295430B6 (fr)
DE (1) DE69637788D1 (fr)
DK (1) DK0836601T3 (fr)
DZ (1) DZ2057A1 (fr)
EE (1) EE03444B1 (fr)
ES (1) ES2318850T3 (fr)
HK (1) HK1010193A1 (fr)
HR (1) HRP960232A2 (fr)
HU (1) HUP9901717A3 (fr)
IL (1) IL122811A (fr)
IS (1) IS2666B (fr)
MA (1) MA23921A1 (fr)
MY (1) MY114018A (fr)
NO (1) NO313008B1 (fr)
NZ (1) NZ311842A (fr)
PL (1) PL186702B1 (fr)
PT (1) PT836601E (fr)
RS (1) RS49826B (fr)
RU (1) RU2144031C1 (fr)
SA (1) SA96170103B1 (fr)
SI (1) SI0836601T1 (fr)
SK (1) SK284780B6 (fr)
TN (1) TNSN96090A1 (fr)
TR (1) TR199701754T1 (fr)
TW (1) TW444010B (fr)
UA (1) UA49838C2 (fr)
WO (1) WO1997002261A1 (fr)
ZA (1) ZA965205B (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
EP0983263A1 (fr) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Nouveaux benzimidazoles utilises comme agents antiulcereux, leur procede de preparation et compositions pharmaceutiques les contenant
WO1999038513A1 (fr) * 1998-01-30 1999-08-05 Sepracor Inc. Compositions et procedes d'utilisation du r-lansoprazole
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
TWI275587B (en) 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PT1191025E (pt) 1999-06-30 2005-09-30 Takeda Pharmaceutical Cristais de lansoprazol
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
ES2511774T3 (es) 2000-05-15 2014-10-23 Takeda Pharmaceutical Company Limited Formas cristalinas de (R)-lansoprazol
WO2002012225A1 (fr) 2000-08-04 2002-02-14 Takeda Chemical Industries, Ltd. Sels de composé à base de benzimidazole et leurs applications
DK1337525T3 (da) 2000-12-01 2011-09-19 Takeda Pharmaceutical Fremgangsmåde til krystallisering af (R)- eller (S)-lansoprazol
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0104295D0 (sv) * 2001-12-18 2001-12-18 Astrazeneca Ab New process
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
EP1552833B1 (fr) 2002-10-16 2016-12-28 Takeda Pharmaceutical Company Limited Procédé de préparation d'un iosmère optiquement actif du lansoprazole
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
DE10254167A1 (de) 2002-11-20 2004-06-09 Icon Genetics Ag Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
BR0316702A (pt) 2002-12-06 2005-10-18 Altana Pharma Ag xprocesso para preparação de (s)-pantoprazol
PT1578742E (pt) 2002-12-06 2013-01-24 Nycomed Gmbh Processo para preparar compostos activos opticamente puros
TWI367759B (en) * 2003-02-20 2012-07-11 Santarus Inc A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
BRPI0407906A (pt) * 2003-02-28 2006-02-14 Ranbaxy Lab Ltd polimorfos de s-omeprazol
AU2004257864A1 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7005732B2 (en) * 2003-10-21 2006-02-28 Honeywell International Inc. Methods and systems for providing MEMS devices with a top cap and upper sense plate
FR2863609A1 (fr) * 2003-12-15 2005-06-17 Isochem Sa Procede d'enrichissement enantiomerique d'un melange d'enantiomeres d'alpha-aminoacides
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
EP1801110A1 (fr) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Sel d'arginine d'ésoméprazole
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
FR2909380B1 (fr) * 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
EP1947099A1 (fr) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Procédé pour l'élimination de solvant des sels d'oméprazole
WO2008152462A1 (fr) * 2007-06-15 2008-12-18 Emcure Pharmaceuticals Limited Procédé de sulfoxydation de composés biologiquement actifs
CN101323609B (zh) * 2007-06-15 2013-05-01 成都福瑞生物工程有限公司 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
CL2009000547A1 (es) 2008-03-10 2010-05-07 Takeda Pharmaceuticals Co Forma cristalina de (r)-2[[[3-metil-4-(2,2,2-trifluoroetoxi)-2-piridinil]metil]sulfinil]-1h-bencimidazol, metodo de preparacion; composicion farmaceutica y su uso para la profilaxis o tratamiento de ulcera peptica, gastritis, esofagitis erosiva, esofago de barret,dispepsia funcional, cancer gastrico.
US8354541B2 (en) 2008-11-18 2013-01-15 Hetero Research Foundation Optical purification of esomeprazole
KR101001646B1 (ko) * 2008-12-12 2010-12-17 한미약품 주식회사 (ｒ)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체
WO2011004387A2 (fr) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Procédé de préparation de formes polymorphes du dexlansoprazole
WO2011058569A1 (fr) 2009-11-12 2011-05-19 Hetero Research Foundation Procédé de dédoublement de l'oméprazole
CA2788147A1 (fr) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited Procede pour la preparation de formes cristallines de dexlansoprazole
AU2015297705B2 (en) * 2014-07-30 2019-12-19 Aetas Pharma Co., Ltd. Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same
ES2615637T3 (es) 2015-03-06 2017-06-07 F.I.S.- Fabbrica Italiana Sintetici S.P.A. Procedimiento mejorado para la purificación óptica del esomeprazol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) * 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
ES2057338T3 (es) * 1989-11-29 1994-10-16 Toa Eiyo Ltd Derivados de cicloheptenopiridina, procedimiento para su preparacion y agentes antiulcerosos que los contienen.
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds

Also Published As

Publication number Publication date
TW444010B (en) 2001-07-01
EP1498416A1 (fr) 2005-01-19
PL186702B1 (pl) 2004-02-27
NZ311842A (en) 1998-12-23
ES2318850T3 (es) 2009-05-01
CZ421197A3 (cs) 1998-06-17
NO976030D0 (no) 1997-12-22
CN1193971A (zh) 1998-09-23
KR19990028631A (ko) 1999-04-15
ATE418549T1 (de) 2009-01-15
JP4195507B2 (ja) 2008-12-10
SA96170103B1 (ar) 2006-07-30
DE69637788D1 (de) 2009-02-05
HUP9901717A2 (hu) 2000-04-28
RU2144031C1 (ru) 2000-01-10
YU37696A (sh) 1999-03-04
AU6324096A (en) 1997-02-05
MY114018A (en) 2002-07-31
HUP9901717A3 (en) 2002-03-28
PT836601E (pt) 2009-02-17
SK179397A3 (en) 1998-09-09
UA49838C2 (uk) 2002-10-15
EP0836601A1 (fr) 1998-04-22
DK0836601T3 (da) 2009-03-16
CZ295430B6 (cs) 2005-08-17
ZA965205B (en) 1997-01-03
IL122811A0 (en) 1998-08-16
EP0836601B1 (fr) 2008-12-24
TNSN96090A1 (fr) 2005-03-15
JPH11508590A (ja) 1999-07-27
TR199701754T1 (xx) 1998-04-21
EE03444B1 (et) 2001-06-15
MX9800160A (es) 1998-03-31
IL122811A (en) 2000-11-21
NO313008B1 (no) 2002-07-29
BR9609450A (pt) 1999-03-02
HRP960232A2 (en) 1998-02-28
KR100451078B1 (ko) 2004-11-16
US5929244A (en) 1999-07-27
MA23921A1 (fr) 1996-12-31
CA2226184A1 (fr) 1997-01-23
IS4638A (is) 1997-12-22
CN1098261C (zh) 2003-01-08
SI0836601T1 (sl) 2009-04-30
NO976030L (no) 1998-02-09
IS2666B (is) 2010-08-15
PL324394A1 (en) 1998-05-25
SK284780B6 (sk) 2005-11-03
RS49826B (sr) 2008-08-07
DZ2057A1 (fr) 2002-10-20
WO1997002261A1 (fr) 1997-01-23
AU698638B2 (en) 1998-11-05
CA2226184C (fr) 2008-08-05
EE9700368A (et) 1998-06-15

Similar Documents

Publication Publication Date Title
IL122811A0 (en) A process for the optical purification of enantiomerically enriched benzimidazole derivatives
EP0764673A3 (fr) Procédé de préparation de polycarbonate
AU7062496A (en) Process for the production of Bis(silyalkyl)-disulfanes
IL122339A (en) Optically active (s)-(+) enantiomers of 2-imidiazoline-5-thione derivatives
FI960278A (fi) Anataasititaanidioksidin valmistusmenetelmä
HUP9900110A3 (en) Novel process for the synthesis of omeprazole
IL124645A0 (en) Process for the production of 1, 2-bis (acyloxylates)
GR3032600T3 (en) Process for the production of imidazo-benzodiazepine derivatives
IL108883A0 (en) Process for the production of hollow carbon fiber membranes
GB2294256B (en) Apparatus for the production of oxygen
HU913180D0 (en) Process for the production of optically active amines
EE03393B1 (et) Protsess enantiomeerselt puhta asetidiin-2-karboksüülhappe saamiseks
ZA963132B (en) Process for the preparation of pure enantiomers of 1-2-pyridyl)-2-cyclo-hexylethylamine.
EP0474250A3 (en) Enzymatic process for separating the optical isomers of racemic 1,2-diols
EP0864597A4 (fr) Procedes de production de polycarbonate
FR2738825B1 (fr) Procede de purification d'un 1,3-bis(3-aminopropyl)-1,1, 3,3-tetraorgano-disiloxane
FR2721312B1 (fr) Procédé de fabrication d'halogénoalcanols.
EP0783039A4 (fr) Procede pour produire des derives de 2-alcoxycyclohexanol optiquement actifs
EP0728722A3 (fr) Procédé pour la production d'hydroxyméthylcyclopropane
FR2742450B1 (fr) Procede pour la production d'hypochlorite
EP0728723A3 (fr) Procédé pour la production de fluorènebisphénol
ZA965169B (en) Process for the production of enantiomerically-pure azeti-dine-2-carboxylic acid

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20160625